• Return to Headlines

Shares of Albany Molecular Rank the Highest in Terms of EBITDA Growth in the Life Sciences Tools & Services Industry (AMRI, NEO, Q, INCR, BIO)

By Nick Russo

Below are the three companies in the Life Sciences Tools & Services industry with the highest EBITDA Growth (next year estimate vs. LTM). EBITDA Growth can be valuable in predicting future cash flow generation and earnings power.

Albany Molecular ranks highest with a EBITDA growth of 229.1%. Neogenomics Inc is next with a EBITDA growth of 136.2%. Quintiles Ims Ho ranks third highest with a EBITDA growth of 95.4%.

Inc Research H-A follows with a EBITDA growth of 89.7%, and Bio-Rad Labs-A rounds out the top five with a EBITDA growth of 81.8%.

SmarTrend recommended that subscribers consider buying shares of Albany Molecular on April 13th, 2017 as our technology indicated a new Uptrend was in progress when shares hit $15.39. Since that recommendation, shares of Albany Molecular have risen 41.4%. We continue to monitor Albany Molecular for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: highest ebitda growth albany molecular nasdaq:neo neogenomics inc quintiles ims ho inc research h-a bio-rad labs-a

Ticker(s): AMRI Q INCR BIO